Home Applications 022363 Application 022363
Type NDA
Sponsor KOWA CO Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LIVALO PITAVASTATIN CALCIUM TABLET;ORAL EQ 1MG BASE Yes No 002 LIVALO PITAVASTATIN CALCIUM TABLET;ORAL EQ 2MG BASE Yes No 003 LIVALO PITAVASTATIN CALCIUM TABLET;ORAL EQ 4MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022363-001 LIVALO PITAVASTATIN CALCIUM EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 N022363-002 LIVALO PITAVASTATIN CALCIUM EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 N022363-003 LIVALO PITAVASTATIN CALCIUM EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 84e616aacf4f…2026-09-14 22:38:34 2026-08 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 84e616aacf4f…2026-08-18 06:07:40 2026-07 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022363-002 LIVALO EQ 2MG BASE TABLET / ORAL AB RLD 2009-08-03 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022363-003 LIVALO EQ 4MG BASE TABLET / ORAL AB RLD, RS 2009-08-03 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022363-001 LIVALO EQ 1MG BASE TABLET / ORAL AB RLD 2009-08-03 301d65b070ca…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 129 observed states.
Observed Orange Book patent history# Patent history page 1 of 12 · 465 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-001 8557993 2024-02-02 Drug product 2013-11-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-001 7022713 2024-02-19 U-998 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-001 8557993*PED 2024-08-02 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-001 7022713*PED 2024-08-19 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-002 8557993 2024-02-02 Drug product 2013-11-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-002 7022713 2024-02-19 U-998 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-002 8557993*PED 2024-08-02 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-002 7022713*PED 2024-08-19 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-003 8557993 2024-02-02 Drug product 2013-11-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-003 7022713 2024-02-19 U-998 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-003 8557993*PED 2024-08-02 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022363-003 7022713*PED 2024-08-19 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-001 8557993 2024-02-02 Drug product 2013-11-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-001 7022713 2024-02-19 U-998 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-001 8557993*PED 2024-08-02 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-001 7022713*PED 2024-08-19 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-002 8557993 2024-02-02 Drug product 2013-11-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-002 7022713 2024-02-19 U-998 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-002 8557993*PED 2024-08-02 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-002 7022713*PED 2024-08-19 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-003 8557993 2024-02-02 Drug product 2013-11-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-003 7022713 2024-02-19 U-998 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-003 8557993*PED 2024-08-02 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022363-003 7022713*PED 2024-08-19 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-001 8557993 2024-02-02 Drug product 2013-11-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-001 7022713 2024-02-19 U-998 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-001 8557993*PED 2024-08-02 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-001 7022713*PED 2024-08-19 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-002 8557993 2024-02-02 Drug product 2013-11-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-002 7022713 2024-02-19 U-998 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-002 8557993*PED 2024-08-02 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-002 7022713*PED 2024-08-19 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-003 8557993 2024-02-02 Drug product 2013-11-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-003 7022713 2024-02-19 U-998 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-003 8557993*PED 2024-08-02 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022363-003 7022713*PED 2024-08-19 Pediatric extension 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-001 8557993 2024-02-02 Drug product 2013-11-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-001 7022713 2024-02-19 U-998 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-001 8557993*PED 2024-08-02 Pediatric extension d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022363-001 7022713*PED 2024-08-19 Pediatric extension d8e5a09893c0…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 108 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 66869-104 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-104 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-104 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-204 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-204 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-204 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-404 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-404 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current 66869-404 Livalo pitavastatin calcium Kowa Pharmaceuticals America, Inc. NDA Current